<DOC>
	<DOCNO>NCT02930499</DOCNO>
	<brief_summary>The purpose pilot study compare incidence rate wound heal subject venous ulcer treat extracellular matrix compose hyaluronic acid plus compression therapy compare standard care . The study also intend follow subject 16-week period order evaluate ulcer recurrence within treatment group .</brief_summary>
	<brief_title>Effect Hyaluronic Acid ECM Venous Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>1 . Male female patient 1885 year age chronic venous insufficiency ( CVI ) presence venous ulceration longer 2 month 2 . Subject and/or caregiver must willing able tolerate multilayered compression bandage 3 . Study subject must reliable , responsible able visit clinic weekly full 16 week period . 1 . Ulcers nonvenous etiology 2 . Subject know sensitivity hyaluronic acid 3 . Presence wound infection determine clinical sign symptoms 4 . Subject evidence peripheral arterial disease ( PAD ) 5 . Subject receive growth factor therapy ( e.g. , autologous plateletrich plasma gel , becaplermin , bilayered cell therapy , dermal substitute , extracellular matrix ) within two week screen date . 6 . Pregnancy lactation time treatment . 7 . Subject currently receive receive radiation chemotherapy within 3 month randomization . 8 . Subject currently enrol participate within 30 day baseline another investigational device , drug biological trial . 9 . History alcohol drug abuse . 10 . Subject allergic broad spectrum primary &amp; secondary dressing material , include occlusive dressing adhesives dressing .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>